Back to search

National and Kapodistrian University of Athens

Μελέτη του ρόλου διαφόρων πρωτεϊνών (αποΑ-Ι, μεταφορείς χοληστερόλης, ένζυμα) του μονοπατιού της HDL

Abstract

dc:description

Although low levels of high-density lipoprotein (HDL) -cholesterol have been associated with increased risk factor for cardiovascular disease, recent studies suggested that HDL functions are determined by the quality rather than by the quantity of HDL. HDL exists in multiple subpopulations that differ in size, shape, and composition. The main protein constituent of HDL is apolipoprotein A-I (apoA-I) that confers many of HDL functions. HDL antiatherogenic properties include its ability to remove cholesterol from cells, such as macrophages in the artery wall, as well as anti-inflammatory, anti-oxidant, vasodilatory, and antithrombotic properties. The aim of the current study was to characterize the HDL properties under pathologic conditions, as well as understand the pathways that affect the HDL properties. Analysis of HDL in families with monogenic low HDL disorders showed that mutations in apoA-I, ABCA1 or LCAT, three proteins that are involved in the HDL biogenesis pathway, affect HDL composition that leads to reduced antioxidant/anti-inflammatory capacity of HDL and result to distinctly different apoA-I-containing HDL subpopulation profiles. These types of analyses could prove valuable in differential diagnosis of familial low HDL syndromes. In addition, we studied the role of apoA-I in the ability of HDL to promote cellular cholesterol efflux mediated by ABCG1, a cholesterol transporter associated with the prevention of cholesterol accumulation in macrophages within multiple tissues. Our findings showed that ABCG1-mediated efflux of cholesterol and to a much lesser effect of 7-ketocholesterol is decreased by deletion of the carboxyl-terminal domain from full-length apoA-I bound to reconstituted HDL (rHDL). The capacity of rHDL containing wild-type apoA-I to promote ABCG1-dependent cholesterol efflux was also significantly reduced following limited proteolysis of rHDL by plasmin, a protease found in the arterial intima. Therefore, our findings may have physiological significance since increased proteolysis, under pathologic conditions, of HDL-associated apoA-I in vivo may affect the capacity of HDL to promote cholesterol efflux from macrophages. Our results, taken as whole, provide new knowledge on how HDL properties can be affected under pathologic conditions. An improved understanding of HDL function and dysfunction will help us identify new targets for diagnosis, prognosis, therapy and prevention of low HDL cholesterol and atherosclerosis.

Degree

thesis:*
Grantor dc:publisher
National and Kapodistrian University of Athens
Year dc:date
2013

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Daniil, Georgios
  • Δανιήλ, Γεώργιος

Subjects

dc:subject × 17

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/38554

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Daniil, Georgios; Δανιήλ, Γεώργιος. Μελέτη του ρόλου διαφόρων πρωτεϊνών (αποΑ-Ι, μεταφορείς χοληστερόλης, ένζυμα) του μονοπατιού της HDL. National and Kapodistrian University of Athens, 2013. http://hdl.handle.net/10442/hedi/38554